Advisory Alpha’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-682
Closed -$67.9K 964
2019
Q3
$67.9K Buy
+682
New +$64.8K 0.02% 211
2019
Q2
Sell
-638
Closed -$60.9K 739
2019
Q1
$60.9K Buy
+638
New +$55.8K 0.02% 209

Other funds holding CELG

Advisory Alpha's CELG Position: Q4 2019 in Review

Advisory Alpha sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 682 shares — an estimated $67.9K sold.

Advisory Alpha first reported a position in CELG in Q1 2019 and held it in 2 quarters. The position peaked at $67.9K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Advisory Alpha reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Advisory Alpha sold 682 Celgene Corp shares in Q4 2019, an estimated $67.9K.
  • Advisory Alpha first reported a position in Celgene Corp in Q1 2019 and held it in 2 quarters.
  • Advisory Alpha's Celgene Corp position peaked at $67.9K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Advisory Alpha's 13F filing for Q4 2019, filed 14 Feb 2020.